Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lung cancer]

A Haugen1

  • 1Toksikologisk seksjon Statens arbeidsmiljøinstitutt, Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|August 6, 1998
PubMed
Summary

Researchers are advancing lung cancer understanding through molecular markers and genetic alterations for early detection. Utilizing multiple molecular markers in sputum or lavage fluid can improve diagnosis and prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A rare missense mutation in CHRNA4 associates with smoking behavior and its consequences.

Molecular psychiatry·2016
Same author

Molecular characterization of a cancer-related single nucleotide polymorphism in the pro-inflammatory interleukin-1B gene.

Molecular carcinogenesis·2012
Same author

Cellular transformation by chemicals and oncogernes gene transfer and phenotypic changes.

Cytotechnology·2012
Same author

Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyrene.

British journal of cancer·2004
Same author

Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cells.

British journal of cancer·2004
Same author

Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years.

International journal of epidemiology·2003

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Lung cancer research is rapidly advancing, identifying key molecular events and susceptibility factors.
  • Genetic alterations like p53 mutations, K-ras, rb, myc amplification, and microsatellite instability are implicated in lung cancer development.

Purpose:

  • To explore novel molecular techniques for early lung cancer detection using sputum or bronchoalveolar lavage fluid.
  • To assess the utility of molecular markers in lung cancer diagnosis, prognosis, and screening.

Summary:

  • Significant progress in understanding lung cancer molecular pathogenesis has led to the discovery of susceptibility factors and genetic alterations.
  • Molecular markers (e.g., p53, K-ras, rb mutations, myc, Her-2/neu amplification, 3p deletion, microsatellite instability) in bodily fluids offer potential for early detection.
  • Combining multiple markers is recommended to enhance the detection of tumors and premalignant lesions.

Impact:

  • These molecular findings have the potential to be integrated into clinical practice for improved lung cancer management.
  • Future research should focus on large prospective studies to validate these molecular detection methods.
  • Early detection and improved prognosis through molecular profiling can significantly impact patient outcomes.

Related Experiment Videos